Studies have reported that angiotensin-converting enzyme 2 (ACE2) has been identified as an infection receptor for severe acute respiratory syndrome (SARS-CoV-2), thus finding drugs that target and inhibit its expression will be the key to treating coronavirus (Barlow et al., 2020). The gene discussed is ACE2; the disease is severe acute respiratory syndrome.